Thursday 15 October 2026
Export ELDN’s income statement to Excel — free account
Eledon Pharmaceuticals, Inc.
ELDN Healthcare Biotechnology
In the quarter to June 2026, EPS fell 107.7% and free cash flow fell 28.0%, each against the same quarter a year earlier.
2.27
0.02
+0.89%
Follow ELDN
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
133.34 | 140.18 | 51.10 | 56.41 | 84.83 | 114.20 | 8.79 | 12.97 | 17.30 | 1.12 |
Total current assets |
135.69 | 143.73 | 56.13 | 59.52 | 88.35 | 115.63 | 9.97 | 14.28 | 19.00 | 1.15 |
Property, Plant, Equpment (Net) |
— | — | — | — | — | — | 0.01 | 0.01 | 0.03 | 0.03 |
Goodwill and Intangible Assets (Total) |
— | — | — | — | 48.65 | 48.65 | — | 1.87 | 1.87 | — |
Long-term assets (Other) |
32.71 | 32.75 | 32.57 | 32.54 | 32.79 | 32.77 | 0.64 | 0.87 | — | 0.02 |
Total non-current assets |
33.32 | 33.68 | 32.94 | 33.28 | 82.20 | 81.56 | 0.96 | 2.75 | 1.89 | 0.05 |
Total Assets |
169.01 | 177.41 | 89.07 | 92.79 | 170.55 | 197.19 | 10.93 | 17.03 | 20.89 | 1.20 |
Accounts Payable |
3.63 | 5.83 | 0.97 | 2.20 | 1.81 | 1.37 | 0.33 | 0.69 | 0.42 | 0.34 |
Accrued Expenses |
14.36 | 5.43 | 2.55 | 3.91 | 2.22 | 0.97 | 0.81 | 1.85 | 1.02 | 0.11 |
Current Part of Debt |
— | — | — | — | — | — | — | — | — | 3.45 |
Total current liabilities |
18.34 | 11.58 | 3.90 | 6.48 | 4.40 | 2.48 | 1.32 | 2.53 | 1.44 | 3.90 |
Long Term Tax Liability (Deferred) |
2.19 | 2.18 | 1.75 | 1.75 | 1.75 | 4.11 | — | — | — | — |
Non-current Liabilities (Other) |
11.42 | 44.87 | 76.21 | — | — | 0.00 | — | — | — | — |
Total non-current liabilities |
13.89 | 47.69 | 77.96 | 2.14 | 2.15 | 4.11 | 0.14 | — | — | — |
Total liabilities |
32.23 | 59.27 | 81.86 | 8.61 | 6.55 | 6.59 | 1.47 | 2.53 | 1.44 | 3.90 |
Additional Paid In Capital |
482.19 | 417.95 | 270.89 | 287.03 | 278.88 | 270.97 | 67.05 | 56.05 | 46.95 | 11.38 |
Preferred Stock (Total) |
55.69 | 55.69 | 55.69 | — | — | — | — | — | — | 0.02 |
Common Stock (Net) |
0.08 | 0.06 | 0.02 | 0.01 | 0.01 | 0.02 | 0.00 | 0.01 | 0.01 | — |
Retained Earnings |
(401.20) | (355.59) | (319.40) | (202.86) | (114.90) | (80.39) | (57.58) | (41.57) | (27.51) | (14.39) |
Shareholders Equity (Other) |
— | — | — | — | — | — | — | — | — | 0.29 |
Common Equity (Total) |
81.09 | 62.45 | (48.49) | 84.18 | 164.00 | 190.60 | 9.47 | 14.49 | 19.45 | (2.72) |
Shareholders Equity (Total) |
136.78 | 118.14 | 7.21 | 84.18 | 164.00 | 190.60 | 9.47 | 14.49 | 19.45 | (2.70) |
Shareholders Equity and Liabilities (Total) |
169.01 | 177.41 | 89.07 | 92.79 | 170.55 | 197.19 | 10.93 | 17.03 | 20.89 | 1.20 |
Shares (Common) |
75.43 | 59.79 | 24.21 | 13.78 | 14.31 | 15.16 | 0.72 | 0.52 | 0.40 | 0.02 |
Shares (Preferred) |
0.11 | 0.11 | 0.11 | 0.12 | 0.11 | 0.11 | — | — | — | 1.09 |
Shareholders Equity (Tangible) |
136.78 | 118.14 | 7.21 | 84.18 | 115.35 | 141.95 | 9.47 | 12.63 | 17.59 | (2.70) |
Net Debt |
(133.34) | (140.18) | (51.10) | (56.41) | (84.83) | (114.19) | (8.79) | (12.97) | (17.30) | 2.33 |
Total Debt |
— | — | — | 0.75 | 0.77 | 0.14 | 0.32 | — | — | 3.45 |
In millions of $ except per-share values · columns are period end dates